BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 26443851)

  • 1. Genotoxicity of flubendazole and its metabolites in vitro and the impact of a new formulation on in vivo aneugenicity.
    Tweats DJ; Johnson GE; Scandale I; Whitwell J; Evans DB
    Mutagenesis; 2016 May; 31(3):309-21. PubMed ID: 26443851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical toxicity and pharmacokinetics of a new orally bioavailable flubendazole formulation and the impact for clinical trials and risk/benefit to patients.
    Lachau-Durand S; Lammens L; van der Leede BJ; Van Gompel J; Bailey G; Engelen M; Lampo A
    PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007026. PubMed ID: 30650076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aneuploidy: a report of an ECETOC task force.
    Aardema MJ; Albertini S; Arni P; Henderson LM; Kirsch-Volders M; Mackay JM; Sarrif AM; Stringer DA; Taalman RD
    Mutat Res; 1998 Feb; 410(1):3-79. PubMed ID: 9587424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo genotoxicity assessment of the dopamine receptor antagonist molindone hydrochloride.
    Krishna G; Gopalakrishnan G; Goel S
    Environ Mol Mutagen; 2016 May; 57(4):288-98. PubMed ID: 27040600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive interpretation of in vitro micronucleus test results for 292 chemicals: from hazard identification to risk assessment application.
    Kuo B; Beal MA; Wills JW; White PA; Marchetti F; Nong A; Barton-Maclaren TS; Houck K; Yauk CL
    Arch Toxicol; 2022 Jul; 96(7):2067-2085. PubMed ID: 35445829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of chromosomal aberrations, cytotoxicity, and morphological transformation in mammalian cells by the antiparasitic drug flubendazole and the antineoplastic drug harringtonine.
    Huang N; Cerepnalkoski L; Nwankwo JO; Dews M; Landolph JR
    Fundam Appl Toxicol; 1994 Feb; 22(2):304-13. PubMed ID: 8005380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone markers identify the mode of action for compounds positive in the TK6 micronucleus assay.
    Cheung JR; Dickinson DA; Moss J; Schuler MJ; Spellman RA; Heard PL
    Mutat Res Genet Toxicol Environ Mutagen; 2015 Jan; 777():7-16. PubMed ID: 25726170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clastogenic and aneugenic effects of three benzimidazole derivatives in the in vitro micronucleus test using human lymphocytes.
    Van Hummelen P; Elhajouji A; Kirsch-Volders M
    Mutagenesis; 1995 Jan; 10(1):23-9. PubMed ID: 7739397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mode-of-action analysis of the effects induced by nicotine in the in vitro micronucleus assay.
    Smart DJ; Helbling FR; Verardo M; McHugh D; Vanscheeuwijck P
    Environ Mol Mutagen; 2019 Dec; 60(9):778-791. PubMed ID: 31294873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of clastogenic and aneugenic damage in newborn rats.
    Udroiu I; Ieradi LA; Cristaldi M; Tanzarella C
    Environ Mol Mutagen; 2006 Jun; 47(5):320-4. PubMed ID: 16538686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and numerical chromosome aberration inducers in liver micronucleus test in rats with partial hepatectomy.
    Itoh S; Hattori C; Nagata M; Sanbuissho A
    Mutat Res; 2012 Aug; 747(1):98-103. PubMed ID: 22561174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidance on aneugenicity assessment.
    ; More SJ; Bampidis V; Bragard C; Halldorsson TI; Hernández-Jerez AF; Hougaard Bennekou S; Koutsoumanis K; Lambré C; Machera K; Naegeli H; Nielsen SS; Schlatter J; Schrenk D; Turck D; Younes M; Aquilina G; Bignami M; Bolognesi C; Crebelli R; Gürtler R; Marcon F; Nielsen E; Vleminckx C; Carfì M; Martino C; Maurici D; Parra Morte J; Rossi A; Benford D
    EFSA J; 2021 Aug; 19(8):e06770. PubMed ID: 34386097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New DNA probes to detect aneugenicity in rat bone marrow micronucleated cells by a pan-centromeric FISH analysis.
    Takeiri A; Motoyama S; Matsuzaki K; Harada A; Taketo J; Katoh C; Tanaka K; Mishima M
    Mutat Res; 2013 Jul; 755(1):73-80. PubMed ID: 23726961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of genetic toxicity of 6-diazo-5-oxo-l-norleucine (DON).
    Kulkarni RM; Dakoulas EW; Miller KE; Terse PS
    Toxicol Mech Methods; 2017 Sep; 27(7):518-527. PubMed ID: 28552037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent aneugenicity of 1-methylpyrene in human cells dependent on metabolic activation by endogenous enzymes.
    Li Z; Yu H; Song M; Glatt H; Liu J; Liu Y
    Arch Toxicol; 2021 Feb; 95(2):703-713. PubMed ID: 33057863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotoxicity and mutagenicity evaluation of isoquercitrin-γ-cyclodextrin molecular inclusion complex using Ames test and a combined micronucleus and comet assay in rats.
    Kapoor MP; Moriwaki M; Timm D; Satomoto K; Minegawa K
    J Toxicol Sci; 2022; 47(6):221-235. PubMed ID: 35650139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacokinetics of mebendazole and flubendazole in animals and man.
    Michiels M; Hendriks R; Heykants J; van den Bossche H
    Arch Int Pharmacodyn Ther; 1982 Apr; 256(2):180-91. PubMed ID: 7103610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thalidomide: lack of mutagenic activity across phyla and genetic endpoints.
    Ashby J; Tinwell H; Callander RD; Kimber I; Clay P; Galloway SM; Hill RB; Greenwood SK; Gaulden ME; Ferguson MJ; Vogel E; Nivard M; Parry JM; Williamson J
    Mutat Res; 1997 Dec; 396(1-2):45-64. PubMed ID: 9434859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can in vitro mammalian cell genotoxicity test results be used to complement positive results in the Ames test and help predict carcinogenic or in vivo genotoxic activity? II. Construction and analysis of a consolidated database.
    Kirkland D; Zeiger E; Madia F; Corvi R
    Mutat Res Genet Toxicol Environ Mutagen; 2014 Dec; 775-776():69-80. PubMed ID: 25435357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.